In mice, ART treatment resulted in small changes in methylation of control-region CpGs for H19, IGF2R, and PEG3, altered expression of these genes, and intrauterine growth restriction (IUGR) [10,17,18,19]. The gene discussed is IGF2R; the disease is fetal growth restriction.